National Institutes of Health: Dermatomyositis trials
The registry lists 17 Dermatomyositis studies with National Institutes of Health as lead sponsor. 5 are open to participants now and 2 have results posted.
Phase 1 1Phase 2 8Phase 3 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)RecruitingNCT07111065Phase 2
- Natural History of Inflammatory Muscle DiseasesRecruitingNCT05738824
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 1
- Environmental Risk Factors for the Anti-synthetase SyndromeRecruitingNCT01276470
- Adult and Juvenile MyositisRecruitingNCT00017914
- COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
- Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult DermatomyositisCompletedNCT03267277Phase 2/3Results posted
- Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile DermatomyositisWithdrawnNCT07012057Phase 2
- Environmental Risk Factors for Myositis in Military PersonnelCompletedNCT01734369
- Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue DiseasesCompletedNCT00341679
- Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile DermatomyositisCompletedNCT00059748
- Infliximab (Remicade ) to Treat Dermatomyositis and PolymyositisCompletedNCT00033891Phase 2
- Safety and Effectiveness of h5G1.1-mAb for DermatomyositisCompletedNCT00005571Phase 2
- Methimazole to Treat Polymyositis and DermatomyositisCompletedNCT00001421Phase 2
- Genetic and Family Studies of Inherited Muscle DiseasesCompletedNCT00001331
- Study and Treatment of Inflammatory Muscle DiseasesCompletedNCT00001265
- Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory MyopathiesCompletedNCT00001261Phase 2